Latest Lactams Stories
The Firm is representing Risperdal lawsuit plaintiffs who allegedly experienced gynecomastia, or male breast growth, due to their use of the antipsychotic medication. New
- EXPEDITION trial results demonstrated QVA149 (indacaterol/glycopyrronium) met all primary and secondary endpoints(1),(2),(3),(4) EAST HANOVER, N.J., May 20, 2015 /PRNewswire/ -- Today, Novartis
LUGANO, Switzerland, May 19, 2015 /PRNewswire/ -- Helsinn, a Swiss Group focused on building quality cancer care, announced today that three abstracts highlighting new
93% of patients treated with INVEGA TRINZA(TM) remained relapse-free at the end of long-term maintenance trial TITUSVILLE, N.J., May 19, 2015 /PRNewswire/ -- There's a new treatment option
CUPERTINO, Calif., May 18, 2015 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it has obtained positive results from a multi-dose Phase 1 clinical trial with an oral
WHIPPANY, N.J., May 15, 2015 /PRNewswire/ -- Bayer HealthCare will present data investigating pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in
DALLAS, May 13, 2015 /PRNewswire-iReach/ -- ReportsnReports.com provides Global Erectile Dysfunction Drugs Market 2014-2018 a market research report in its store.
TITUSVILLE, N.J., May 11, 2015 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. announced today that the U.S.
-- First New Fixed Combination Targeting Two Critical Pathways Involved in CINV MELBOURNE, Australia and LUGANO, Switzerland, May 8, 2015 /PRNewswire/ -- Australian biopharmaceutical company
VANCOUVER, British Columbia and MENLO PARK, Calif., May 7, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).